Filter posts

BIO 2017 Patient and Health Advocacy Summit Explores Best Practices in State Advocacy

The first day of BIO’s Patient Health & Advocacy Summit concluded with a breakout session …

Strategic Venture Investing by Large Pharma: Is “Smart Money” Right for Your Company

The strategic venture arms of major biopharma companies like AbbVie, Amgen, Johnson & Johnson and …

Biosimilars at the Federal Circuit – Can the Parties Be Compelled to Dance?

In 2009, Congress passed the Biologics Price Competition and Innovation Act (“BPCIA”), which for the first …

Cohen, Boyer & Tibbetts?

Ask any biotech professional about Stanley Cohen and Herbert Boyer and they will tell you …

Amgen Hosts Science without Borders Students

This year, Amgen is hosting six Science without Borders undergraduate interns at its Thousand Oaks, …

Banning Gene Patents Will Promote Innovation?

Abolishing gene patents will deter, not promote, innovation, as the patent eligibility of isolated DNA …